Kura Oncology

About

Kura Oncology, Inc. is a clinical-stage biopharmaceutical company focused on the development of targeted therapies for cancer. The company is dedicated to realizing the promise of precision medicine in oncology, developing innovative treatment options that improve the lives of cancer patients. Through a combination of industry-leading expertise and cutting-edge research, Kura Oncology is leveraging an extensive understanding of the molecular mechanisms of cancer. The company works relentlessly to discover and develop small molecule drug candidates that can selectively target specific mutations and pathways involved in cancer progression. Kura is particularly focused on the development of therapies that can provide meaningful benefits to patients with cancers that have been historically considered difficult to treat.